MarketPeel
Pricing
…
MM

Mary Miller

ACRV
CHIEF LEGAL OFFICER · ACRIVON THERAPEUTICS, INC. · CIK 0001841088
FILING MIX · LIFETIME31%/69%
BUYS
12
SELLS
27
TOTAL VALUE
$153.0K
COMPANIES
2
ACTIVE SINCE
Feb 2021
HOLDINGS NOW
465,521
AVG SELL PX
$5.32
TRADE KIND
SHOWING 39 / 39
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Mary Miller, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+100.00%-17.13%-5.52%-11.61%-11.61%—
14d1+100.00%-26.19%-1.95%-24.25%-24.25%—
30d1+100.00%-10.54%-0.15%-10.39%-10.39%—
60d1+100.00%-34.43%-1.63%-32.80%-32.80%—
90d1+100.00%-46.13%-8.29%-37.84%-37.84%—
180d1+0.00%+40.03%-3.26%+43.29%+43.29%—
1y1+100.00%-59.31%-7.09%-52.21%-52.21%—
2y1+100.00%-82.54%+15.39%-97.93%-97.93%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ACRV · 82,009 shares · as of Aug 18, 2026
032,44064,88097,320129,760202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
2026
FLOW · 12 buys / 27 sellsCOVERAGE · 23 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ACRV
ACRIVON THERAPEUTICS, INC.
SALE
Chief Legal Officer
185$2.01$37282,009Aug 18, 2026Aug 20, 2026 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
SALE
Chief Legal Officer
573$1.76$1.0K82,194Jul 21, 2026Jul 23, 2026 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
49,830——82,767May 18, 2026May 20, 2026 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
SALE
Chief Legal Officer
184$1.92$35332,937May 14, 2026May 18, 2026 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
SALE
Chief Legal Officer
558$1.78$99333,121Apr 17, 2026Apr 21, 2026 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
129,760——129,760Mar 1, 2026Mar 3, 2026 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
SALE
Chief Legal Officer
217$1.63$35433,679Feb 14, 2026Feb 18, 2026 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
SALE
Chief Legal Officer
659$1.98$1.3K33,896Jan 17, 2026Jan 21, 2026 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
SALE
Chief Legal Officer
184$2.24$41234,555Nov 14, 2025Nov 18, 2025 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
SALE
Chief Legal Officer
558$1.81$1.0K34,739Oct 17, 2025Oct 21, 2025 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
SALE
Chief Legal Officer
284$1.81$51435,297Oct 1, 2025Oct 3, 2025 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
SALE
Chief Legal Officer
184$1.39$25635,581Aug 14, 2025Aug 18, 2025 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
SALE
Chief Legal Officer
558$1.32$73735,765Jul 17, 2025Jul 21, 2025 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
SALE
Chief Legal Officer
184$1.14$21036,323May 14, 2025May 16, 2025 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
SALE
Chief Legal Officer
558$1.81$1.0K36,507Apr 17, 2025Apr 18, 2025 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
15,616——15,616Apr 1, 2025Apr 3, 2025 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
93,693——93,693Mar 1, 2025Mar 4, 2025 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
SALE
Chief Legal Officer
217$5.42$1.2K37,065Feb 14, 2025Feb 19, 2025 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
SALE
Chief Legal Officer
659$5.78$3.8K37,282Jan 17, 2025Jan 22, 2025 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
SALE
Chief Legal Officer
184$7.92$1.5K37,941Nov 14, 2024Nov 18, 2024 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
SALE
Chief Legal Officer
558$7.87$4.4K38,125Oct 17, 2024Oct 21, 2024 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
SALE
Chief Legal Officer
284$6.98$2.0K38,683Oct 1, 2024Oct 3, 2024 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
SALE
Chief Legal Officer
184$7.02$1.3K38,967Aug 14, 2024Aug 16, 2024 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
SALE
Chief Legal Officer
558$7.69$4.3K39,151Jul 17, 2024Jul 19, 2024 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
SALE
Chief Legal Officer
184$8.36$1.5K39,709May 14, 2024May 16, 2024 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
SALE
Chief Legal Officer
558$10.34$5.8K39,893Apr 17, 2024Apr 19, 2024 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
67,567——67,567Mar 1, 2024Nov 27, 2024 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
SALE
Chief Legal Officer
217$3.40$73840,451Feb 14, 2024Feb 16, 2024 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
SALE
Chief Legal Officer
652$4.35$2.8K40,668Jan 17, 2024Jan 19, 2024 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
SALE
Chief Legal Officer
735$5.08$3.7K41,320Nov 14, 2023Nov 16, 2023 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
SALE
Chief Legal Officer
2,232$5.48$12.2K42,055Oct 17, 2023Oct 19, 2023 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
3,858——44,287Sep 26, 2023Sep 28, 2023 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
11,576——11,576Sep 26, 2023Sep 28, 2023 ↗View →
BFLY
BUTTERFLY NETWORK, INC.
PURCHASEGRANT
Stock grant
54,789——383,512Mar 22, 2022Mar 24, 2022 ↗View →
BFLY
BUTTERFLY NETWORK, INC.
PURCHASEGRANT
Stock grant
189,655——328,723Mar 4, 2022Mar 8, 2022 ↗View →
BFLY
BUTTERFLY NETWORK, INC.
SALE
General Counsel & Corp Sec
16,677$5.95$99.3K139,068Feb 16, 2022Feb 17, 2022 ↗View →
BFLY
BUTTERFLY NETWORK, INC.
PURCHASEGRANT
Stock grant
259,575——259,575Feb 12, 2021Feb 25, 2021 ↗View →
BFLY
BUTTERFLY NETWORK, INC.
PURCHASEGRANT
Stock grant
259,575——259,575Feb 12, 2021Feb 16, 2021 ↗View →
BFLY
BUTTERFLY NETWORK, INC.
PURCHASEGRANT
Stock grant
155,745——155,745Feb 12, 2021Feb 25, 2021 ↗View →
Other insiders · ACRV
Loading peer insiders…
About this filer
CIK 0001841088
ROLE
Chief Legal Officer
PRIMARY
ACRV
COMPANIES
2
ACTIVE SINCE
Feb 2021
MARKETPEEL · /INSIDER/0001841088DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback